Glaxo smith-kline-presentation
-
Upload
harram-aneeqa -
Category
Health & Medicine
-
view
30 -
download
1
Transcript of Glaxo smith-kline-presentation
GSK’S Introduction
•3rd largest pharmaceutical company in the world based on
revenues
•Leading market share in 4 of the 5 largest therapeutic markets
•5 % of the global pharmaceuticals market.
•1,100 prescriptions are written for one of its products every
minute.
•Spends over $450,000 every hour on R & D.
Company profile
Chairman: Sir Christopher Gent
•Headquarters: London, UK
•Global operations: Over 115 countries
•Stock Listing: Primary - London Stock Exchange
Secondary – New York Stock Exchange
•Revenue (2010): £ 28.4 billion
GSK’s Mission
SIMPLYFY
GROW
DELIVER
MISSION
GSK MISSION
Products
1. Prescription medicines
2. Vaccines
3. Consumer Healthcare
Consumer care products Vaccines
Medicines
PRESCRIPTION MEDICINES
ALLI-WEIGHT LOSS DRUG
AVANDIA-DIABETIS CONTROL
VACCINE FOR MEASLES
CONSUMER HEALTHCARE PRODUCTS
Corporate Culture
• Working at GSK• Engaging and developing employees• Diversity• Improving health and safety• Core values• Collaboration with doctors
New Market Entrants :• Recognized Marketing Code
Barriers to Entry :• Government policy• Brand Recognition
Competitive Priority :• Highly Competitive• Low Fixed Costs & High
Working Capital• Differentiation Strategy
Buyers Powers :• Consumers do not have
bargaining power.• Price sensitivity is less.• Brand identity in the hands
of influencer.
Power of Product and Technology Development :• Reforming R & D• Entrants of New Vaccines by 2011 end.• Restructuring for Diversity and
Strengthening.
Porters Five Forces Model for Developing Countries
(Porter, 2008)
Marketing
• Marketing strategy changes according to the region where the group is providing its products.
• GSK’s marketing strategy is different they always innovate new medicines as well as they enhance its old products with mild alterations and deliver it to the consumer accordingly
Entry Modes
• Licensing agreements• Joint ventures• Wholly owned Subsidiaries• Acquisitions
Where GSK stands Globally
• GSK has largest global presence in over 115 countries• Employed 99,000 people with12,500 in R&D• 7% share of Global market• Fourth largest pharmaceutical company
World market by geographic region
value(billion pounds) % of total• USA 187 40• Europe 131 28• France 25 5• Germany 24 5• Italy 16 3• UK 12 3• Rest of World 150 32• Emerging markets 66 14• Asia Pacific 20 4• Japan 50 11• Canada 11 2
Partnerships
• NHS• Non profit- organizations • The academic world
Global partnerships
• In September 2011, GSK and the McLaren Group joined forces to share knowledge and expertise with the aim of improving business performance and driving a more dynamic business culture.
Gsk in pakistan
• GlaxoSmithKline Pakistan is one of the leading pharmaceutical companies in Pakistan